| 发明名称 | Use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug | ||
| 摘要 | The present invention relates to the use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug. | ||
| 申请公布号 | US9320745(B2) | 申请公布日期 | 2016.04.26 |
| 申请号 | US200712295269 | 申请日期 | 2007.03.28 |
| 申请人 | TROPHOS | 发明人 | Pruss Rebecca;Buisson Bruno;Bordet Thierry |
| 分类号 | A01N45/00;A61K31/56;A61K31/575 | 主分类号 | A01N45/00 |
| 代理机构 | Browdy and Neimark, PLLC | 代理人 | Browdy and Neimark, PLLC |
| 主权项 | 1. A method for decreasing the risk of acquiring a cardiovascular disease in a cancer patient receiving doxorubicin, comprising administering to the patient a composition comprising cholest-4-en-3-one oxime or one of its addition salts with pharmaceutically acceptable acids. | ||
| 地址 | Marseilles FR | ||